Pulse Pressure Linked to Multiple Adverse Cardiovascular Outcomes

Share this content:
Pulse Pressure Linked to Multiple Adverse Cardiovascular Outcomes
Pulse Pressure Linked to Multiple Adverse Cardiovascular Outcomes

TUESDAY, Jan. 26, 2016 (HealthDay News) -- Pulse pressure (PP) is associated with multiple adverse cardiovascular outcomes, according to a study published online Jan. 25 in the Journal of the American College of Cardiology.

Senthil Selvaraj, M.D., from the Brigham and Women's Hospital Heart and Vascular Center in Boston, and colleagues examined whether PP is associated with major adverse cardiovascular outcomes in participants from the international Reduction of Atherothrombosis for Continued Health (REACH) registry. Data were included for 45,087 participants, excluding those with incomplete four-year follow-up or PP data.

The researchers found that the mean blood pressure was 138 ±19/79 ± 11 mm Hg, for a mean PP of 49 ± 16 mm Hg. Increasing PP quartile correlated with worse outcomes on univariate analysis (P < 0.05 for all comparisons). PP quartile was still associated with all outcomes except all stroke and cardiovascular death after adjustment for sex, age, current smoking status, history of hypercholesterolemia, history of diabetes, aspirin use, statin use, blood pressure medication use, and mean arterial pressure (P < 0.05 for all comparisons).

"In an international cohort of high-risk subjects, PP, a readily available hemodynamic parameter, is associated with multiple adverse cardiovascular outcomes and provides prognostic utility beyond that of mean arterial pressure," the authors write.

Several authors disclosed financial ties to biopharmaceutical companies, including Sanofi and Bristol-Myers Squibb, which sponsored the REACH registry.

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

NIH Panel Will No Longer Review Gene Therapy Experiments

NIH Panel Will No Longer Review Gene Therapy ...

FDA will now assess gene therapy experiments and products as it does with other treatments, drugs

Doctors Remove Contact Lens Embedded in Eyelid for Years

Doctors Remove Contact Lens Embedded in Eyelid for ...

Lens was encapsulated within the upper eyelid soft tissue since childhood eye trauma

CDC: Brucellosis in Dogs Remains a Public Health Risk

CDC: Brucellosis in Dogs Remains a Public Health ...

Infection is under-recognized, may remain a threat without stronger intervention measures

is free, fast, and customized just for you!




Already a member?

Sign In Now »